36 36

Cited 0 times in

1년 이상 생존한 췌장암환자의 임상적 특징

DC FieldValueLanguage
dc.contributor.author정재복-
dc.date.accessioned2020-07-03T17:50:19Z-
dc.date.available2020-07-03T17:50:19Z-
dc.date.issued1997-
dc.identifier.issn1976-3573-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/177870-
dc.description.abstractObjectives: Ductal adenocarcinoma of the pancreas is a lethal disease with poor prognosis. 5-year survival of pancreatic adenocarcinoma was less than 5%. To determine which factors effect the prognosis in the patients of pancreatic adenocarcinoma, the authors reviewed the data of the patients who were diagnosed and treated as pancreatic adenocarcinoma and analyzed the difference between survival groups more than 1 year and less than 1year. Method: The records of 242 patients who were diagnosed and treated as pancreatic adenocarcinoma from January 1991 to January 1996 were reviewed retrospectively. Survival and survival time were confirmed by patients interview, letter, hospital chart, and personal contact with the attending physician. Results: 166 of the 242 patients were male and 76 patients female. Mean age of 242 patients was 60.4 years. Overall 1-year survival was 14%. 1-year survival of patients with stage I(n=16) was 54%, stage II(n=37) 19%, stage III(n=63) 17%, and stage IV(n=126) 5%. Median survival time of the patients with ECOG grade 0(n=10) was 14 months, grade 1(n=96) 7 months, grade 2(n=70) 4 months, grade 3(n=45) 2 months, and grade 4(n=20) 1 month. When survival groups more than 1 year(n=34) and less than 1 year(n=208) were compared, the patients of survival group more than 1 year had better general health condition(ECOG grade), less tumor size(2.4±0.7 vs 3.4±2.2 cm), less lymph node involvement(35.3 vs 64.9%) and less distant metastasis(14.7 vs 56.7%) than the patients of survival group less than 1 year. One-year survival of the patients who underwent curative resection(n=23) was 51%, palliative resection(n=33) 25% and no resection(n=186) 7%. The patients of survival group more than 1year were treated by more aggressive and multimodality therapy(operation, chemotherapy, radiotherapy) than the patients of survival group less than 1year. All 5 patients of stage IV who survived more than 1year were belonged to ECOG grade 1. No metastatic lesion was found by radiologic study before operation but metastatic lesions were found at operation in all 5 patients. All 5 patients were treated by adjuvant chemotherapy after operation. Conclusion: The patients of survival group more than 1 year had better general health condition(ECOG grade), less tumor size, less lymph node involvement, less distant metastasis and were treated more aggressive therapy than the patients of survival group less than 1year.-
dc.description.statementOfResponsibilityopen-
dc.languageKorean-
dc.publisher대한췌담도연구회-
dc.relation.isPartOf대한췌담도연구회지-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.title1년 이상 생존한 췌장암환자의 임상적 특징-
dc.title.alternativeClinical Characteristics of One-year Survivors of Pancreatic Cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthor황영웅-
dc.contributor.googleauthor정정일-
dc.contributor.googleauthor이기명-
dc.contributor.googleauthor장준호-
dc.contributor.googleauthor정재복-
dc.contributor.googleauthor송시영-
dc.contributor.googleauthor강진경-
dc.contributor.googleauthor박인서-
dc.contributor.localIdA03706-
dc.relation.journalcodeJ03689-
dc.identifier.eissn2288-0941-
dc.contributor.alternativeNameChung, Jae Bock-
dc.contributor.affiliatedAuthor정재복-
dc.citation.volume2-
dc.citation.number1-
dc.citation.startPage1-
dc.citation.endPage7-
dc.identifier.bibliographicCitation대한췌담도연구회지, Vol.2(1) : 1-7, 1997-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.